Viewing Study NCT04689308


Ignite Creation Date: 2025-12-26 @ 10:57 AM
Ignite Modification Date: 2025-12-26 @ 10:57 AM
Study NCT ID: NCT04689308
Status: UNKNOWN
Last Update Posted: 2021-09-08
First Post: 2020-12-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: This is a Phase 1 Study of MH048 in Patients With Selected Relapsed/Refractory B-cell Malignancies
Sponsor: Minghui Pharmaceutical (Shanghai) LTD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module